Spatial relationship of the C-terminal domains of dystrophin and β- dystroglycan in cardiac muscle support a direct molecular interaction at the plasma membrane interface

Circulation Research

Volumn 82, Issue 1, 1998, Pages 82-93

  Stevenson, Shirley ^a   Rothery, Stephen ^a   Cullen, Michael J ^b   Severs, Nicholas J ^a,c  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Confocal microscopy; Cytoskeleton; Dystrophin; Freeze fracture cytochemistry; dystroglycan

Indexed keywords

DYSTROGLYCAN; DYSTROPHIN;

ARTICLE; BECKER MUSCULAR DYSTROPHY; CARDIOMYOPATHY; CELL ULTRASTRUCTURE; CONFOCAL MICROSCOPY; CYTOSKELETON; DUCHENNE MUSCULAR DYSTROPHY; EXTRACELLULAR MATRIX; HEART MUSCLE FIBER MEMBRANE; HUMAN TISSUE; MALE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT;

EID: 0031906423     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.82.1.82     Document Type: Article

References (54)

1. Ervasti JM, Ohlendieck K, Kahl SD, Gaver MG, Campbell KP. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature. 1990;345:315-319.
2. Ervasti JM, Campbell KP. Membrane organisation of the dystrophin-glycoprotein complex. Cell. 1991;66:1121-1131.
3. Campbell KP. Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell. 1995;80:675-679.
4. Ibraghimov-Beskrovnaya O, Evarsti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature. 1992; 355:696-702.
5. Yoshida M, Ozawa E. Glycoprotein complex anchoring dystrophin to sarcolemma. J Biochem. 1990;108:748-752.
6. Campbell KP, Kahl SD. Association of dystrophin and an integral glycoprotein. Nature. 1989;338:259-262.
7. Ohlendieck K. Towards an understanding of the dystrophin-glycoprotein complex: linkage between the extracellular matrix and the membrane cytoskeleton in muscle fibers. Eur J Cell Biol. 1996;69:1-10.
8. Brown RH Jr. Dystrophin-associated proteins and the muscular dystrophies: A glossary. Brain Pathol. 1996;6:19-24.
9. Tinsley JM, Blake DJ, Zuellig RA, Davies KE. Increasing complexity of the dystrophin-association protein complex. Proc Natl Acad Sci U S A. 1994;91:8307-8313.
10. Cullen MJ, Walsh J, Nicholson LV. Immunogold localisation of the 43-kDa dystroglycan at the plasma membrane in control and dystrophic human muscle. Acta Neuropathol. 1994;87:349-354.
11. Deyst KA, Bowe MA, Leszyk JD, Fallon JR. The α-dystroglycan-βdystroglycan complex. J Biol Chem 1995;270:25956-25959.
12. Ervasti JM, Campbell KP. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol. 1993; 122:809-823.
13. Suzuki A, Yoshida M, Yamamoto H, Ozawa E. Glycoprotein-binding site of dystrophin is confined to the cysteine-rich domain and the first half of the carboxy-terminal domain. FEBS Lett. 1992;308:154-160.
14. Suzuki A, Yoshida M, Hayashi K, Mizuno Y, Hagiwara Y, Ozawa E. Molecular organisation at glycoprotein-complex-binding site of dystrophin: three dystrophin-associated proteins bind directly to the carboxy-terminal portion of dystrophin. Eur J Biochem. 1994;220:283-292.
15. Ganote CE, Armstrong S. Ischaemia and the myocyte cytoskeleton. Cardiovasc Res. 1993;27:1387-1403.
16. Hoffman EP. Clinical and histopathological features of abnormalities of the dystrophin-based membrane cytoskeleton. Brain Pathol. 1996;6:49-61.
17. Matsumura K, Tome FMS, Ionasescu V, Ervasti JM, Anderson RD, Romero NB, Simon D, Recan D, Kaplan J, Fardeau M. Deficiency of dystrophin-associated proteins in Duchenne muscular dystrophy patients lacking COOH terminal domains of dystrophin. J Clin Invest. 1993;92:866-871.
18. Ohlendieck K, Campbell KP. Dystrophin-associated proteins are gready reduced in skeletal muscle from mdx mice. J Cell Biol. 1991;115:1685-1694.
19. Ohlendieck K, Matsumura K, Ionasescu VV, Towbin JA, Bosch EP, Weinstein SL, Sernett SW, Campbell KP. Duchenne muscular dystrophy: deficiency of dystrophin-associated proteins in the sarcolemma. Neurology. 1993;43:795-800.
20. Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci U S A. 1993;90:3710-3714.
21. Nawrotzki R, Blake DJ, Davies KE. The genetic basis of neuromuscular disorders. Trends Genet. 1996;12:294-298.
22. Nigro V, de Sa Moreira E, Piluso U, Vainzof M, Belsito A, Politano L, Puca AA, Passos-Bueno MR, Zatz M. Autosomal recessive limb-girdle muscular dystrophy LGMD2F, is caused by a mutation in the δ-sarcoglycan gene. Nat Genet. 1996;1:49-58.
23. Jung D, Leturcq F, Sunada Y, Duclos F, Tomé FMS, Moomaw C, Merlini L, Azibi K, Chaouch M, Slaughter C, Fardeau M, Kaplan JV, Campbell KP. Absence of gamma-sarcoglycan (35DAG) in autosomal recessive muscular dystrophy linked to chromosome 13q12. FEBS Lett. 1996;381:15-20.
24. Vainzof M, Passos-Bueno MR, Canovas M, Sa Moreira E, Pavanello RCM, Marie SK, Anderson LVB, Bonnemann CG, Mc Nally EM, Nigro V, Kunkel LM, Zatz M. The sarcoglycan complex in the six autosomal recessive limb-girdle muscular dystrophies. Hum Mol Genet. 1996;5:1963-1969.
25. Barresi R, Confalonieri V, Lanfossi M, Di Blasi C, Torchiana E, Mantegazza R, Jarre L, Nardocci N, Boffi P, Tezzon F, Pini A, Cornelio F, Mora M, Morandi L. Concomitant deficiency of β-and γ-sarcoglycans in 20 α-sarcoglycan (adhalin)-deficient patients: immunohistochemical analysis and clinical aspects. Acta Neuropathol. 1997;94:28-35.
26. Nigro V, Okazaki Y, Belsito A, Matsuda Y, Politano G., Nigro C, Ventura C, Abbondanza AM, Molinari D, Acampora M, Nishimura Y, Hayashizaki Y, Puca GA. Identification of the Syrian hamster cardiomyopathy gene. Hum Mol Genet. 1997;6:601-607.
27. Williamson RA, Henry MD, Daniels KJ, Hrstka RF, Lee JC, Sunada Y, Ibraghimov-Beskrovnaya O, Campbell KP. Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice. Hum Mol Genet. 1997;6:831-841.
28. Jung D, Yang B, Meyer J, Chamberlain JS, Campbell KP. Identification and characterisation of the dystrophin anchoring site on β-dystroglycan. J Biol Chem. 1995;270:27305-27310.
29. Rosa G, Ceccarini M, Cavaldesi M, Zini M, Petrucci T. Localisation of the dystrophin binding site at the carboxy terminus of β-dystroglycan. Biochem Biophys Res Commun. 1996;223:272-277.
30. Wakayama Y, Shibuya S, Takeda A, Jimi T, Nakamura Y, Oniki H. Ultrastructural localisation of the C-terminus of the 43-kd dystrophin-associated glycoprotein and its relation to dystrophin in normal murine skeletal myofiber. Am J Pathol. 1995;146:189-196.
31. Inoue M, Wakayama Y, Murahashi M, Shibuya S, Takahiro J, Kojima H, Oniki H. Electron microscopic observations of triple immunogold labelling for dystrophin, β-dystroglycan and adhalin in human skeletal myofibres. Acta Neuropathol. 1996;92:569-575.
32. Arahata K, Ishiura T, Tsukahara T, Suhara Y, Eguchi C, Ishihara T, Nonaka I, Ozawa E, Sugita H. Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide. Nature. 1988;333:861-863.
33. Klietsch R, Ervasti JM, Arnold W, Campbell KP, Jorgensen AO. Dystrophin-glycoprotein complex and laminin colocalize to the sarcolemma and transverse tubules of cardiac muscle. Circ Res. 1993;72:349-360.
34. Green CR, Severs NJ. Distribution and role of gap junctions in normal myocardium and human ischaemic heart disease. Histochemistry. 1993;99:105-120.
35. Severs NJ. Cardiac muscle cell interaction: from microanatomy to the molecular make-up of the gap junction. Histol Histopathol. 1995;10: 481-501.
36. Pinto da Silva P, Barbosa MLF, Aguas AP. A guide to fracture-label: cytochemical labeling of freeze-fractured cells. In: Koehler JK, ed. Advanced Techniques in Biological Electron Microscopy. New York, NY: Springer Verlag; 1986;3:201-227.
37. Stevenson S, Rothery S, Cullen MJ, Severs NJ. Dystrophin is not a specific component of the cardiac costamere. Circ Res. 1997;80:269-280.
38. Pinto da Silva P, Kachar B, Torrisi MR, Brown C, Parkison C. Freeze-fracture cytochemistry: replicas of critical point-dried cells and tissues after fracture-label. Science. 1981;213:230-233.
39. Fujimoto K. Freeze-fracture replica electron microscopy combined with SDS digestion for cytochemical labeling of integral membrane proteins: application to the immunogold labeling of intercellular junctional complexes. J Cell Sci. 1995;108:3443-3449.
40. Severs NJ. Freeze-fracture cytochemistry: an explanatory survey of methods. In: Severs NJ, Shotton DM, eds. Rapid Freezing, Freeze Fracture, and Deep Etching. New York, NY: Wiley-Liss Inc; 1995:173-208.
41. Pinto da Silva P, Parkison C, Dwyer N. Freeze-fracture cytochemistry: thin sections of cells and tissues after labeling of fracture faces. J Histochem Cytochem. 1981;29:917-928.
42. Squarzoni S, Sabatelli P, Maltarello MC, Cataldi A, Di Primio R, Maraldi NM. Localization of dystrophin COOH-terminal domain by the fracture-label technique. J Cell Biol. 1992;118:1401-1409.
43. Ahn AH, Kunkel LM. The structural and functional diversity of dystrophin. Nat Genet. 1993;3:283-291.
44. Campbell KP, Crosbie RH. Utrophin to the rescue. Nature. 1996;384: 308-309.
45. Suzuki A, Yoshida M, Ozawa E. Mammalian α1-and β1-syntrophin bind to alternative splice-prone region of the dystrophin COOH terminus. J Cell Biol. 1995;128:373-381.
46. Hoffman EP, Hudecki MS, Rosenberg PA, Pollina CM, Kunkel LM. Cell and fiber-type distribution of dystrophin. Neuron. 1988;1:411-420.
47. Emery AEH. Duchenne Muscular Dystrophy, Oxford, England: Oxford Medical Publications; 1993:24. Oxford Monographs on Medical Genetics.
48. Carter LF, Rubin SA. The molecular and cellular biology of heart failure. Curr Opin Cardiol. 1994;9:264-271.
49. Hunsaker RH, Fulkerson PK, Barry FJ, Lewis RP, Lefier CV, Unverferth DV. Cardiac function in Duchenne's muscular dystrophy: result of 10-year follow-up study and non-invasive test. Am J Med. 1982;73:235-238.
50. Franz WM, Cremer M, Herrmann R, Grünig E, Fogel W, Scheffold T, Goebel HH, Kircheisen R, Kübler W, Voit T, Katus HA. X-linked dilated cardiomyopathy: novel mutation of the dystrophin gene. Ann N Y Acad Sci. 1995;752:470-491.
51. Muntoni F, Wilson L, Marrosu MG, Cianchetti C, Mestroni L, Ganau A, Dubowitz V, Sewry C. A mutation in the dystrophin gene selectively affecting dystrophin expression in the heart. J Clin Invest. 1995;96: 693-699.
52. Towbin JA, Hejtmancik JF, Brink P, Gelb B, Zhu XM, Chamberlain JS, McCabe ERB, Swift M. X-linked dilated cardiomyopathy: molecular genetic evidence of linkage to Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation. 1993;87:1854-1865.
53. Yoshida K, Ikeda S, Nakamura A, Kagoshima M, Takeda S, Shoji S, Yanagisawa N. Molecular analysis of the Duchenne muscular dystrophy gene in patients with Becker muscular dystrophy presenting with dilated cardiomyopathy. Muscle Nerve. 1993;16:1161-1166.
54. Brown RH. Dystrophin-associated proteins and the muscular dystrophies. Annu Rev Med. 1997;48:457-466.